Diabetes

Latest

Bacillus Calmette-Guerin Vaccination Lowers HbA1c in Type 1 Diabetes

Bacillus Calmette-Guerin Vaccination Lowers HbA1c in Type 1 Diabetes

Bacillus Calmette-Guerin vaccination impacted blood sugar levels in T1D by causing a systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis.

Severity of Metabolic Syndrome Indicates Risk for T2D, CVD in Prediabetes Treatment

Severity of Metabolic Syndrome Indicates Risk for T2D, CVD in Prediabetes Treatment

Researchers analyzed how improvements in metabolic syndrome may impact the risk of developing type 2 diabetes and cardiovascular disease in patients with prediabetes.

Patients With Diabetes Have Higher Risk for Death From Alcohol, Accidents, Suicide

Patients With Diabetes Have Higher Risk for Death From Alcohol, Accidents, Suicide

Patients with diabetes have increased mortality due to suicide, alcohol-related causes, and accidents than those without diabetes.

Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy

Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy

The artificial intelligence-based deep learning algorithm shows robust performance in the detection of vision-threatening referable diabetic retinopathy.

Bone-Derived Factors in the Treatment of Diabetes

Bone-Derived Factors in the Treatment of Diabetes

A growing body of research highlights the important role of bone in glucose metabolism.

Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D

Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D

For patients with severe obesity and type 2 diabetes, bariatric surgery is associated with a lower risk for macrovascular outcomes compared with not undergoing surgery.

Periodic Fasting May Reduce Medication Use in T2D

Periodic Fasting May Reduce Medication Use in T2D

Medically supervised, therapeutic fasting regimens can help reverse type 2 diabetes (T2D) and minimize the need for pharmacological interventions.

Cost a key consideration of WHO guidelines for diabetes treatment intensification

WHO guidelines recommend selecting sulfonylureas as the single best second-line agent for Type 2 Diabetes Mellitus (T2DM) patients.

Sign Up for Free e-Newsletters



CME Focus